Joining Forces to Build a New High Ground in the Health Industry, jointly Promoting Pharmaceutical Innovation and Global Development in China
September 3, 2025, Visum Pharma R&D Center — The atmosphere was both solemn and vibrant as Zhongnuo Caring and Visum Pharmaceutical held a grand ceremony to mark the official launch of their strategic collaboration. This signing is not only a significant milestone in deepening the cooperation between the two parties but also symbolizes the formal establishment of a new framework characterized by "complementary advantages and synergistic development" within the health industry, injecting powerful momentum into high-quality sector growth.
Gathering of Elites, Celebrating the Momentous Occasion
The core teams from both companies were present in full force. Leaders and distinguished guests, including Tao Gang, Chairman of Zhongnuo Caring; Cai Yiting, General Manager; Zhu Honggang, Chairman of Visum Pharma, and Dr. Tan Haisong, Chief Scientist, gathered together to witness this landmark moment. Amidst a dignified ceremonial atmosphere, the signing venue resonated with applause, marking the glorious beginning of this partnership.
Delivering a speech, Planning an blueprint
At the beginning of the ceremony, Tao Gang, Chairman of Zhongnuo Caring , delivered a speech. He stated that Zhongnuo Caring, rooted in the Hainan Free Trade Port, always adhered to its original aspiration of "Dedicated to Excellence, Devoted to people", and focus on critical areas such as drug-resistant tuberculosis and hematologic tumors. The company has gradually built comprehensive capabilities spanning "from innovative R&D to clinical accessibility." Visum Pharmaceutical, as an internationally leading CDMO platform enterprise, is becoming a benchmark for China's pharmaceutical industry in its journey toward globalization, leveraging its first-class formulation development, international registration, and manufacturing capabilities. Chairman Tao Gang emphasized that this partnership is a natural choice driven by mutual trust and complementary strengths, as well as a deep integration of technological innovation and industrial upgrading.
Subsequently, Zhu Honggang, Chairman of Visum Pharmaceutical, reviewed the profound long-standing connection between the two companies. Chairman Zhu looked into the future and stated that Visum Pharmaceutical would rely on its "superior quality and manufacturing capabilities" to join forces with Zhongnuo Caring in the field of tuberculosis treatment. He candidly expressed, “Profit is secondary; it is our true honor to contribute to the treatment of tuberculosis patients in China and around the world.” He further emphasized his expectation that both parties will leverage their respective strengths to achieve a synergistic effect where “1+1>2”. He also mentioned that both companies were making layout in the capital market and could further pursue resource sharing and mutual development in the future.
Enterprise Demonstration Complementary Advantages
At the meeting, Cai Yiting, General Manager of Zhongnuo Caring, and Zeng Mengchun, Secretary of the Board of Directors of Visum Pharmaceutical, respectively introduced the development history and core competitiveness of their enterprises.
Zhongnuo Caring showed its channel layout deeply rooted in the national market, mature service system, and brand concept of "patient-centered";
Visum Pharmaceutical,on the other hand, focuses on its R&D capabilities, technological breakthroughs, and industrial implementation outcomes, highlighting its leading advantages in international registration and industrialization.
The two parties complement and support each other, forming a complete strategic synergy chain covering the "R&D - Production - Market" cycle.
Strategic Signing: Moving Forward Hand in Hand
Amid warm applause, Dennis Tao, Chairman of Zhongnuo Caring, and Zhu Honggang, Chairman of Visum Pharmaceutical, signed the strategic cooperation agreement on behalf of both parties—marking that the two sides will carry out in-depth cooperation in formulation development, technology transfer, international registration, industrialization, market expansion, and other areas.
After the signing, the participants held in-depth discussions on the industry's prospects, clarifying that in the future, they will promote the transformation from "segmented operations" to "full-chain integration" and move from "single-point breakthroughs" to "platform empowerment", joining hands to build a sustainable industrial community.
Looking to the Future: Jointly Building a Healthy China
In the future, guided by the original aspiration of "long-term trust and continuous co-construction", the two parties will give full play to their respective advantages and jointly build an internationally competitive pharmaceutical industry ecosystem. The collaboration between Zhongnuo Caring and Visum Pharmaceutical is not only a cooperation between enterprises, but also a vivid practice of China’s pharmaceutical industry aligning with national strategies and driving industrial upgrading. The two parties will shoulder the mission of "enabling more patients to access high-quality and accessible medicines", and jointly write a new chapter in China’s pharmaceutical industry stepping onto the global stage.
